Daniel Kolk

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 14 CIPO patents and 12 EPO patents, primarily in Viral Pathogen Detection. Top assignees: Gen-Probe, Inc., Bank of America, N.a., as Collateral Agent. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Kolk. Retrieved from https://idiyas.com/inventor/daniel-kolk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 85.0

CIPO Patents = 14 (Patent Applications = 8)

EPO Patents = 12 (Patent Applications = 16)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 95(Granted Patents)

Company Filing History:

Bank of America, N.a., as Collateral Agent

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Viral Pathogens

Adenovirus

Hepatitis B Virus

Human Parainfluenza Virus

Rhinovirus

Nucleic Acids

Detection Methods

Quantification Techniques

Amplification Reactions

Parvovirus B19

Influenza Detection

Compositions and Kits

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649950 - COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES (2026-06-09),

2. 12497655 - COMPOSITIONS, METHODS AND KITS TO DETECT ADENOVIRUS, METAPNEUMOVIRUS AND/OR RHINOVIRUS NUCLEIC ACIDS (2025-12-16),

3. 12460255 - Compositions and methods to detect adenovirus nucleic acids and metapneumovirus and/or rhinovirus nucleic acids (2025-11-04),

4. 12428672 - Compositions and methods for detecting or quantifying Human Parainfluenza Virus 4 (2025-09-30),

5. 12404541 - Compositions and methods for detecting or quantifying human parainfluenza virus 2 (2025-09-02),

6. 12398420 - Compositions to detect adenovirus nucleic acids (2025-08-26),

7. 12338491 - Methods to detect rhinovirus nucleic acids (2025-06-24),

8. 12116620 - Compositions and methods for detecting or quantifying parainfluenza virus (2024-10-15),

9. 11976337 - Methods for detection of influenza in samples (2024-05-07),

10. 11384387 - Compositions, methods and kits to detect adenovirus nucleic acid (2022-07-12),

11. 10844425 - Compositions and methods for detecting or quantifying parainfluenza virus (2020-11-24),

12. 10745767 - Compositions and methods for detecting hepatitis B virus (2020-08-18),

13. 9914982 - Compositions and methods for detecting hepatitis B virus (2018-03-13),

14. 9109264 - Compositions and methods for detecting hepatitis B virus (2015-08-18),

15. 8541171 - Assay for detection of human parvovirus B19 nucleic acid (2013-09-24),

Title: The Innovative Contributions of Daniel Kolk

Introduction

Daniel Kolk is a prominent inventor based in Ramona, California, known for his significant contributions to the field of virology. With a total of 17 patents to his name, Kolk has made remarkable advancements in the detection and quantification of human parainfluenza viruses.

Latest Patents

Kolk's latest patents include innovative compositions and methods for detecting or quantifying Human Parainfluenza Virus 4. These patents provide compositions, methods, kits, and uses for detecting or quantifying HPIV-1, HPIV-2, HPIV-3, and HPIV-4 nucleic acids, utilizing nucleic acid amplification and hybridization assays. In some embodiments, the compositions target the HN gene of HPIV-1, HPIV-2, and HPIV-3, as well as the NP gene of HPIV-4. Additionally, he has developed similar compositions and methods for detecting or quantifying Human Parainfluenza Virus 2, further showcasing his expertise in this critical area of research.

Career Highlights

Kolk is currently associated with Gen-Probe, Inc., where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in enhancing the understanding and detection of parainfluenza viruses, which are significant pathogens in human health.

Collaborations

Throughout his career, Kolk has collaborated with notable colleagues, including Mehrdad R Majlessi and Pamela Douglass. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Daniel Kolk's innovative work in the field of virology, particularly in the detection of human parainfluenza viruses, has established him as a leading inventor. His contributions continue to impact the scientific community and improve public health outcomes.

Profile summary based on public USPTO records.